| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA010369 |
| P698 | PubMed publication ID | 11784873 |
| P2093 | author name string | Tiziana Meschi | |
| Loris Borghi | |||
| Angela Guerra | |||
| Umberto Maggiore | |||
| Franca Allegri | |||
| Almerico Novarini | |||
| Tania Schianchi | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention | Q1717246 |
| P304 | page(s) | 77-84 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria | |
| P478 | volume | 346 |
| Q44680811 | 1alpha-Hydroxylase gene ablation and Pi supplementation inhibit renal calcification in mice homozygous for the disrupted Npt2a gene |
| Q43030405 | A nomogram for the prediction of kidney stone recurrence |
| Q28486066 | A pilot study of the effect of sodium thiosulfate on urinary lithogenicity and associated metabolic acid load in non-stone formers and stone formers with hypercalciuria |
| Q35588351 | ACP Best Practice No 181: Chemical pathology clinical investigation and management of nephrolithiasis |
| Q37524134 | Activity, energy intake, obesity, and the risk of incident kidney stones in postmenopausal women: a report from the Women's Health Initiative |
| Q45841973 | An individualized weight-based goal urine volume model significantly improves expected calcium concentrations relative to a 2-L goal urine volume |
| Q36521140 | An unusual patient with hypercalciuria, recurrent nephrolithiasis, hypomagnesemia and G227R mutation of Paracellin-1. An unusual patient with hypercalciuria and hypomagnesemia unresponsive to thiazide diuretics |
| Q36631128 | Analgesic Effects of Inhalation of Nitric Oxide (Entonox) and Parenteral Morphine Sulfate in Patients with Renal Colic; A Randomized Clinical Trial. |
| Q46929650 | Antioxidant therapy prevents ethylene glycol-induced renal calcium oxalate crystal deposition in Wistar rats |
| Q40689843 | Arguments for a comprehensive metabolic evaluation of the first-time stone former |
| Q46883161 | Artificial neural networks for assessing the risk of urinary calcium stone among men. |
| Q38687067 | Association between multiple chronic conditions and urolithiasis |
| Q34625474 | Association between schizophrenia and urinary calculi: a population-based case-control study |
| Q36486436 | Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia |
| Q38254465 | Association of serum biochemical metabolic panel with stone composition |
| Q28387493 | Asymptomatic kidney stones in long-term survivors of childhood acute lymphoblastic leukemia |
| Q80540731 | Bariatric surgery, hyperoxaluria, and nephrolithiasis: a plea for close postoperative management of risk factors |
| Q44791095 | Biochemical markers of bone metabolism and calciuria with inhaled budesonide therapy |
| Q36059334 | Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug |
| Q37195350 | Bone disease in pediatric idiopathic hypercalciuria |
| Q37585262 | CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update |
| Q89861538 | Calcium Oxalate Nephrolithiasis and Gut Microbiota: Not just a Gut-Kidney Axis. A Nutritional Perspective |
| Q22306250 | Calcium Supplementation in Clinical Practice: A Review of Forms, Doses, and Indications |
| Q37012166 | Calcium fortificants: overview and strategies for improving calcium nutriture of the U.S. population |
| Q36658936 | Calcium intake and disease prevention |
| Q36451158 | Calcium intake and urinary stone disease |
| Q44591952 | Calcium oxalate stones and hyperoxaluria. What is certain? What is new? |
| Q37290799 | Calcium supplementation and incident kidney stone risk: a systematic review |
| Q26471306 | Calcium supplementation for weight reduction in overweight or obese people |
| Q36667112 | Calcium-sensing receptor attenuates AVP-induced aquaporin-2 expression via a calmodulin-dependent mechanism |
| Q50760121 | Changes in upper urinary tract stone composition in Australia over the past 30 years. |
| Q47105900 | Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers |
| Q82315083 | Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome |
| Q46034967 | Chitosan does not reduce post-prandial urinary oxalate excretion. |
| Q35021693 | Clinical implications of physicochemistry of stone formation |
| Q35335724 | Clinical practice. Calcium kidney stones |
| Q34265048 | Clinical review. Kidney stones 2012: pathogenesis, diagnosis, and management |
| Q36067858 | Comparative effects of low-carbohydrate high-protein versus low-fat diets on the kidney. |
| Q91808499 | Compliance in patients with dietary hyperoxaluria: A cohort study and systematic review |
| Q59812095 | Confounding risk factors and preventative measures driving nephrolithiasis global makeup |
| Q35995984 | Consensus report of the National Medical Association. The role of dairy and dairy nutrients in the diet of African Americans |
| Q38062198 | Cost-effectiveness treatment strategies for stone disease for the practicing urologist |
| Q37367687 | DASH-style diet associates with reduced risk for kidney stones |
| Q36829655 | Dairy intake, dietary adequacy, and lactose intolerance |
| Q58588756 | Defining metabolic activity of nephrolithiasis - Appropriate evaluation and follow-up of stone formers |
| Q36151013 | Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic? |
| Q35050411 | Determinants of brushite stone formation: a case-control study |
| Q28647028 | Determination of Elemental Composition of Malabar spinach, Lettuce, Spinach, Hyacinth Bean, and Cauliflower Vegetables Using Proton Induced X-Ray Emission Technique at Savar Subdistrict in Bangladesh |
| Q36325704 | Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline |
| Q38062190 | Diet and alternative therapies in the management of stone disease |
| Q34547086 | Diet and fluid prescription in stone disease |
| Q46133488 | Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study |
| Q37582208 | Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation |
| Q34079052 | Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials |
| Q28267307 | Diet-induced acidosis: is it real and clinically relevant? |
| Q38220973 | Diet: from food to stone |
| Q38862898 | Dietary and Lifestyle Risk Factors Associated with Incident Kidney Stones in Men and Women |
| Q97545688 | Dietary and lifestyle factors for primary prevention of nephrolithiasis: a systematic review and meta-analysis |
| Q86487596 | Dietary and pharmacological compounds altering intestinal calcium absorption in humans and animals |
| Q35373518 | Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones |
| Q36440909 | Dietary calcium, calcium supplements, and the risk of calcium oxalate kidney stones |
| Q35914380 | Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. |
| Q34560059 | Dietary intake of fiber, fruit and vegetables decreases the risk of incident kidney stones in women: a Women's Health Initiative report |
| Q24200428 | Dietary interventions for preventing complications in idiopathic hypercalciuria |
| Q35541576 | Dietary minerals and modification of cardiovascular risk factors |
| Q38662268 | Dietary recommendations and treatment of patients with recurrent idiopathic calcium stone disease |
| Q37430373 | Dietary treatment of nephrolithiasis |
| Q28509758 | Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis |
| Q36451163 | Economic impact of urinary stones |
| Q46177645 | Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation |
| Q82782407 | Effect of dietary modification on urinary stone risk factors |
| Q46445969 | Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease |
| Q38011454 | Effect of socioeconomic status on 24-hour urine composition in patients with nephrolithiasis |
| Q47919786 | Effectiveness of Treatment Modalities on Kidney Stone Recurrence |
| Q41097725 | Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women |
| Q46123263 | Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients. |
| Q46072255 | Effects of calcium supplementation on body weight reduction in overweight calcium stone formers |
| Q35756780 | Effects of non-pharmacological interventions on urinary citrate levels: a systematic review and meta-analysis |
| Q37078071 | Effects of thiazide on the expression of TRPV5, calbindin-D28K, and sodium transporters in hypercalciuric rats |
| Q93382289 | Empiric therapy for kidney stones |
| Q38128732 | Epidemiological gender-specific aspects in urolithiasis |
| Q26777309 | Epidemiology and treatment of osteoporosis in women: an Indian perspective |
| Q79815451 | Epidemiology of kidney stones in Iceland: a population-based study |
| Q36902334 | Epidemiology of stone disease |
| Q33858018 | Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis |
| Q89745707 | Evaluation and Medical Management of Patients with Cystine Nephrolithiasis: A Consensus Statement |
| Q24630579 | Evaluation and medical management of the kidney stone patient |
| Q44795801 | Evaluation and treatment of pediatric idiopathic urolithiasis-revisited |
| Q36902341 | Evaluation of the recurrent stone former |
| Q42714795 | Evaluation of urinary abnormalities in nephrolithiasis patients from Marathwada region |
| Q36264952 | Evaluation of urinary abnormalities in urolithiasis patients: A study from North India |
| Q35999340 | Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers. |
| Q37401624 | Evidence for durable kidney stone prevention over several decades |
| Q37808369 | Evidence for metabolic origin of absorptive hypercalciuria Type II |
| Q34045989 | Fad diets and their effect on urinary stone formation |
| Q64121092 | Fecal transplant modifies urine chemistry risk factors for urinary stone disease |
| Q51177779 | Gender-related effects on urine L-cystine metastability. |
| Q37283787 | Genetic hypercalciuric stone-forming rats have a primary decrease in BMD and strength |
| Q58118044 | How to Build a Kidney Stone Prevention Clinic |
| Q35597900 | Hypercalciuria associated with high dietary protein intake is not due to acid load |
| Q46944815 | Hypercalciuria revisited: one or many conditions? |
| Q27013855 | Hyperoxaluria: a gut-kidney axis? |
| Q35021708 | Hyperoxaluric calcium nephrolithiasis |
| Q36413105 | Idiopathic hypercalciuria |
| Q38051251 | Idiopathic hypercalciuria and bone health |
| Q38906968 | Idiopathic hypercalciuria and formation of calcium renal stones |
| Q36365178 | Impact of dietary habits on stone incidence |
| Q38062199 | Impact of stone disease: chronic kidney disease and quality of life |
| Q54274278 | In memory of Professor Loris Borghi (1949-2018). |
| Q52601609 | Incidence of kidney stone disease in Icelandic children and adolescents from 1985 to 2013: results of a nationwide study. |
| Q88003866 | Insights Into Nephrolithiasis From the Nurses' Health Studies |
| Q54484639 | Internet program for facilitating dietary modifications limiting kidney stone risk. |
| Q81550812 | Is 24-hour urinary calcium a surrogate marker for dietary calcium intake? |
| Q33682398 | Is the Internet a reliable source for dietary recommendations for stone formers? |
| Q92787461 | Kidney injury in response to crystallization of calcium oxalate leads to rearrangement of the intrarenal T cell receptor delta immune repertoire |
| Q38281436 | Kidney stone analysis: "Give me your stone, I will tell you who you are!". |
| Q24536113 | Kidney stone disease |
| Q85278387 | Kidney stone disease: pathophysiology, investigation and medical treatment |
| Q89217016 | Kidney stones |
| Q24564565 | Kidney stones |
| Q35690040 | Kidney stones in anorexia nervosa: a case report and review of the literature. |
| Q34489092 | Kidney stones: pathophysiology and medical management. |
| Q40619090 | Knowledge, attitudes, and practice patterns of recurrent urinary stones prevention in Saudi Arabia |
| Q92861237 | LIFESTYLE RISK FACTORS AND BONE MASS IN RECURRENT STONE-FORMING PATIENTS: A CROSS-SECTIONAL STUDY IN 144 SUBJECTS |
| Q96762096 | Letter to the Editor - Reply |
| Q84613472 | Lifestyle recommendations to reduce the risk of kidney stones |
| Q37422038 | Lowering urinary oxalate excretion to decrease calcium oxalate stone disease |
| Q24684764 | Management of kidney stones |
| Q40124614 | Mean temperature and humidity variations, along with patient age, predict the number of visits for renal colic in a large urban Emergency Department: results of a 9-year survey. |
| Q40198027 | Mechanisms of Stone Formation |
| Q42250628 | Medical Measures for Secondary Prevention of Urolithiasis |
| Q26777616 | Medical and alternative therapies in urinary tract stone disease |
| Q34698180 | Medical and dietary therapy for kidney stone prevention |
| Q33655278 | Medical care for the final years of life: "When you're 83, it's not going to be 20 years". |
| Q35076411 | Medical evaluation and management of urolithiasis |
| Q35720635 | Medical management of calcium oxalate urolithiasis |
| Q35863767 | Medical management of pediatric stone disease |
| Q35106071 | Medical management of stone disease |
| Q37829770 | Medical therapy for calculus disease |
| Q58588749 | Medical therapy for nephrolithiasis: State of the art |
| Q35021730 | Medical treatment of nephrolithiasis. |
| Q28751145 | Medical treatment of pediatric urolithiasis |
| Q45883811 | Medullary nephrocalcinosis in idiopathic hypercalciuria |
| Q36708606 | Metabolic Evaluation in Paediatric Urolithiasis: A 4-Year Open Prospective Study |
| Q37366264 | Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement |
| Q38270121 | Metabolic evaluation of urinary lithiasis: what urologists should know and do. |
| Q36129839 | Metabolic syndrome and the risk of calcium stones |
| Q36921858 | Metaphylaxis of nephrolithiasis |
| Q35643131 | Metaphylaxis, diet and lifestyle in stone disease |
| Q57222745 | Microorganisms and calcium oxalate stone disease |
| Q38404826 | Multivariate Analyses of Urinary Calculi Composition: A 13-Year Single-Center Study. |
| Q81295660 | Nephrolithiasis |
| Q38191822 | Nephrolithiasis and hypertension: possible links and clinical implications. |
| Q38854569 | Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis |
| Q34936324 | Nephrolithiasis-associated bone disease: pathogenesis and treatment options |
| Q35856057 | Nephrolithiasis: Endocrine evaluation |
| Q36618101 | New insights into the pathogenesis of idiopathic hypercalciuria |
| Q80295945 | Normal-calcium, low-sodium, and low-animal-protein diet for stone prevention |
| Q34934670 | Nutrition and renal stone disease in space |
| Q36836609 | Nutrition in calcium nephrolithiasis |
| Q26801209 | Nutritional Management of Kidney Stones (Nephrolithiasis) |
| Q34553719 | Nutritional aspect of nephrolithiasis |
| Q35021723 | Nutritional aspects of stone disease |
| Q35534406 | Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes |
| Q46172023 | Oral calcium supplementation associated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism |
| Q38837256 | Oxalate, inflammasome, and progression of kidney disease |
| Q35021697 | Pathogenesis of hypercalciuric nephrolithiasis |
| Q36902344 | Pathophysiology and management of calcium stones |
| Q37913747 | Pathophysiology-based treatment of idiopathic calcium kidney stones |
| Q93060014 | Patient's perception of kidney stone prevention within the emergency department and its adherence factors: a single institution study |
| Q36033738 | Pediatric primary urolithiasis: Symptoms, medical management and prevention strategies. |
| Q44359991 | Potential renal acid load and the risk of renal stone formation in a case-control study |
| Q35613110 | Predictive medicine in non-malignant urological disorders |
| Q90349064 | Predictors of Symptomatic Kidney Stone Recurrence After the First and Subsequent Episodes |
| Q35352073 | Preventive fluid and dietary therapy for urolithiasis: An appraisal of strength, controversies and lacunae of current literature |
| Q39604977 | Primary prevention of nephrolithiasis is cost-effective for a national healthcare system |
| Q42816596 | Probiotics and dietary manipulations in calcium oxalate nephrolithiasis: two sides of the same coin? |
| Q83299967 | Problems in the metabolic evaluation of renal stone disease: audit of intra-individual variation in urine metabolites |
| Q83445877 | Pyridoxine and dietary counseling for the management of idiopathic hyperoxaluria in stone-forming patients |
| Q47130387 | Quality of life and urolithiasis: the patient - reported outcomes measurement information system (PROMIS). |
| Q92950491 | Radiation Mitigation Techniques in Kidney Stone Management |
| Q34454068 | Reactive oxygen species, inflammation and calcium oxalate nephrolithiasis |
| Q26748565 | Recent advances in managing and understanding nephrolithiasis/nephrocalcinosis |
| Q58118264 | Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date? |
| Q39967281 | Regional short-term climate variations influence on the number of visits for renal colic in a large urban Emergency Department: results of a 7-year survey |
| Q33913413 | Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis |
| Q39442566 | Renal stone clinic survey: calcium stone formers' self-declared understanding of and adherence to physician's recommendations |
| Q36658996 | Renal stone disease: Causes, evaluation and medical treatment |
| Q43830551 | Risk factors for urinary stones in healthy schoolchildren with and without a family history of nephrolithiasis |
| Q90401127 | Risk of Kidney Stones: Influence of Dietary Factors, Dietary Patterns, and Vegetarian-Vegan Diets |
| Q31057241 | Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature |
| Q42374595 | Roundup |
| Q38230324 | Salt and nephrolithiasis. |
| Q46818521 | Secondary contributors to bone loss in osteoporosis related hip fractures |
| Q38226763 | Secondary hyperoxaluria: a risk factor for kidney stone formation and renal failure in native kidneys and renal grafts |
| Q47117524 | Sodium chloride pica causing recurrent nephrolithiasis in a patient with iron deficiency anemia: a case report |
| Q43275934 | Spanish bottled and tap water analysis and their relation with urinary lithiasis |
| Q34629795 | Stone composition as a function of age and sex. |
| Q38409982 | Stone formation and management after bariatric surgery |
| Q24545733 | Strategies for preventing calcium oxalate stones |
| Q60044936 | Systemic analysis of urinary stones from the Northern, Eastern, Central, Southern and Southwest China by a multi-center study |
| Q41622844 | Tacrolimus Aggravated Tube Feeding Syndrome with Acute Renal Failure in a Pediatric Liver Transplant Recipient |
| Q43800325 | Temporal trends in the incidence of kidney stone disease |
| Q96427835 | The Association Between 24-Hour Urine and Stone Recurrence Among High Risk Kidney Stone Formers: A Population Level Assessment |
| Q36742487 | The CARI guidelines. Kidney stones: prevention of recurrent calcium nephrolithiasis |
| Q61812313 | The Demographic Diversity of Food Intake and Prevalence of Kidney Stone Diseases in the Indian Continent |
| Q37924425 | The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease |
| Q37047425 | The assessment of 24 24-h urine volume by measurement of urine specific gravity with dipstick in adults with nephrolithiasis |
| Q64243774 | The association between dietary intakes and stone formation in patients with urinary stones in Shiraz |
| Q44797265 | The association between the incidence of urolithiasis and nutrition based on Japanese National Health and Nutrition Surveys |
| Q37064844 | The association of nephrolithiasis with hypertension and obesity: a review |
| Q45061116 | The effect of oral administration of calcium and magnesium on intestinal oxalate absorption in humans |
| Q26786250 | The elementome of calcium-based urinary stones and its role in urolithiasis |
| Q37091241 | The health benefits of calcium citrate malate: a review of the supporting science |
| Q83820584 | The impact of dietary calcium and oxalate ratios on stone risk |
| Q35819439 | The impact of dietary oxalate on kidney stone formation. |
| Q37920747 | The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients |
| Q33971034 | The increasing pediatric stone disease problem |
| Q39733750 | The kidney stone and increased water intake trial in steel workers: results from a pilot study |
| Q34769970 | The management of primary hyperparathyroidism |
| Q57485794 | The metabolic stone evaluation: An opportunity for shared decision-making |
| Q35606002 | The potential benefits of dietary and/or supplemental calcium and vitamin D. |
| Q36494400 | The preventive treatment of recurrent stone-formation: how can we improve compliance in the treatment of patients with recurrent stone disease? |
| Q41893736 | The role of Randall's plaques in urolithiasis. Foreword |
| Q44741699 | The role of overweight and obesity in calcium oxalate stone formation |
| Q34999809 | The role of salt abuse on risk for hypercalciuria |
| Q37052780 | The use of calcium and vitamin D in the management of osteoporosis |
| Q34673925 | Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones |
| Q85204422 | Trends in the Medical Management of Urolithiasis: A Comparison of General Urologists and Endourology Specialists |
| Q35216521 | Unified theory on the pathogenesis of Randall's plaques and plugs |
| Q39405280 | Update on the evaluation of repeated stone formers |
| Q51156123 | Updated epidemiologic study of urolithiasis in Turkey. I: Changing characteristics of urolithiasis. |
| Q37070036 | Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health |
| Q42838684 | Urinary lithiasis and idiopathic hypercalciuria: the importance of dietary intake evaluation |
| Q84113807 | Urinary metabolic evaluation of stone formers-a Malaysian perspective |
| Q45092683 | Urolithiasis |
| Q96764305 | Urolithiasis in Children |
| Q44368776 | Urolithiasis in pediatric patients with acute lymphoblastic leukemia. |
| Q37044646 | Urolithiasis, Urinary Cancer, and Home Drinking Water Source in the United States Territory of Guam, 2006-2010. |
| Q37956368 | Urolithiasis--medical therapies |
| Q39119052 | Urolithiasis: evaluation, dietary factors, and medical management: an update of the 2014 SIU-ICUD international consultation on stone disease. |
| Q36001203 | Use of Google Insights for Search to track seasonal and geographic kidney stone incidence in the United States |
| Q55084280 | Vitamin D, Hypercalciuria and Kidney Stones. |
| Q37780944 | WASH-world action on salt and health |
| Q30252153 | Water and other fluids in nephrolithiasis: State of the art and future challenges. |
| Q51090228 | Whey protein and albumin effects upon urinary risk factors for stone formation. |
| Q64938664 | Which Diet for Calcium Stone Patients: A Real-World Approach to Preventive Care. |
| Q79306914 | [Modern general metaphylaxis of stone disease. New risks, new evidence, new recommendations] |
| Q79795058 | [Prevention of nephrolithiasis. Established strategies and new concepts] |
| Q84985850 | [Recurrence prevention of kidney stone disease] |
| Q85048735 | [Recurrence prevention of urolithiasis with respect to economic aspects] |
| Q87714084 | [S2k guidelines on diagnostics, therapy and metaphylaxis of urolithiasis (AWMF 043/025) : Compendium] |
| Q80155337 | [Urinary calculi. Metabolism and diagnosis] |
Search more.